San Francisco, California, United States Trellis Bioscience is the famous Corporate Investor, which was founded in 1998. The leading representative office of defined Corporate Investor is situated in the San Francisco. The venture was found in North America in United States.
The current fund was established by Lawrence Kauvar.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2006. The increased amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Morgenthaler Ventures, HealthCare Ventures. In the next rounds fund is usually obtained by Forbion Capital Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Promedior Among the most successful fund investment fields, there are Therapeutics, Biopharma.
| Fund Name | Location |
| AMT | China, Shanghai |
| Avva Technology Pte Ltd | Central, Central Region, Singapore |
| Canada Innovation Acceleration Investment | - |
| CG Health Ventures | Barcelona, Catalonia, Spain |
| Crescendix | France, Ile-de-France, Paris |
| Crimson Capital | Czechia, Prague, Prague |
| Eideard Venture Capital | - |
| Gradiente Sgr | Italy, Padua, Veneto |
| INDEE Japan | Japan, Tokyo |
| Lucas Point Ventures | New York, New York, United States |
| Metropolitan Venture Partners | New York, New York, United States |
| Neff Capital Management | - |
| Scripps Networks | Knoxville, Tennessee, United States |
| Shanghai Xiangyi Touzi Guanli Youxian Gongsi | China, Shanghai |
| SOUL FI | Lisboa, Lisbon, Portugal |
| VCF III | - |
| Venture Farm | California, Irvine, United States |
| Zhejiang Ausun Pharmaceutical | China, Jiangsu, Taizhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Promedior | $14M | 24 May 2006 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Promedior | $14M | 24 May 2006 | Massachusetts, United States |
